Event | Screen/enroll day 1 | Day 33 | Day 307 | Day 607 | Day 907 | Day 1207 | Day 1507 | Day 1807 | Malaria diagnosis/ recurrence2 |
---|---|---|---|---|---|---|---|---|---|
a. Informed consent | X | Â | Â | Â | Â | Â | Â | Â | Â |
b. Medical history | X | Â | Â | Â | Â | Â | Â | Â | Â |
c. Physical exam | X | Â | Â | Â | Â | Â | Â | Â | X |
d. Brief clinical evaluation and vital signs1 | Â | Â | X | X | X | X | X | X | X |
e. Malaria RDT, DBS, smear and PCR genotyping6 | 2Â mL | Â | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5Â mL |
i. CBC | 1Â mL | 1Â mL3 | Â | Â | Â | Â | Â | Â | Â |
k. Molecular resistance markers2 | Â | Â | Â | Â | Â | Â | Â | Â | 6Â mL |
l. G6PD RDT, fluorescent spot, quantitative testing | 1.5Â mL | Â | Â | Â | Â | Â | Â | Â | Â |
m. Gametocyte PCR | 2.5Â mL | Â | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5Â mL |
n. Urine pregnancy test (women of child-bearing age) | X | Â | X | X | Â | Â | Â | Â | X |
o. Malaria treatment4,5 | X | Â | X | X | Â | Â | Â | Â | X |
Daily phlebotomy (mL) | 7 | 13 | 4 | 4 | 4 | 4 | 4 | 4 | 10 |
Cumulative phlebotomy (approximately mL) | 7 | Â | 11 | 15 | 19 | 23 | 27 | 31 | 41 |